Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion type Assertion NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_head.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion description "[In this study we show that ROS1 is abnormally activated in the CD34+ compartment of approximately 70% of CMML patients resulting in the activation of the Erk/Akt pathways through the Grb2/SOS complex thus revealing a central oncogenic role for ROS1 in CMML which might represent a molecular target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_provenance.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion evidence source_evidence_literature NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_provenance.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion SIO_000772 23415111 NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_provenance.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion wasDerivedFrom befree-20140225 NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_provenance.
- NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_assertion wasGeneratedBy ECO_0000203 NP939016.RA1QCXD-sQufyOn8xBR7EuJ3F_blH_FRfD66D5pN-jGXw130_provenance.